18The DNA-dependent protein kinase (DNA-PK), composed of the KU heterodimer and the 19 large catalytic subunit (DNA-PKcs), is a classical non-homologous end-joining (cNHEJ) 20 factor. Naïve B cells undergo class switch recombination (CSR) to generate antibodies with 21 different isotypes by joining two DNA double-strand breaks at different switching regions via 22 the cNHEJ pathway. DNA-PK and the cNHEJ pathway play important roles in the DNA repair 23 phase of CSR. To initiate cNHEJ, KU binds to DNA ends, and recruits and activates DNA-PK. 24 DNA-PKcs is the best-characterized substrate of DNA-PK, which phosphorylates DNA-PKcs at 25 both the S2056 and T2609 clusters. Loss of T2609 cluster phosphorylation increases radiation 26 sensitivity, suggesting a role of T2609 phosphorylation in DNA repair. Using the DNA-PKcs 5A 27 mouse model carrying an alanine substitution at the T2609 cluster, here we show that loss of 28 T2609 phosphorylation of DNA-PKcs does not affect the CSR efficiency. Yet, the CSR 29 junctions recovered from DNA-PKcs 5A/5A B cells reveal increased chromosomal translocation, 30 excess end-resection, and preferential usage of micro-homologyall signs of the alternative 31 end-joining pathway. Thus, these results uncover a role of DNA-PKcs T2609 phosphorylation 32 in promoting cNHEJ repair pathway choice during CSR. 33 34 Key points 35 Loss of T2069 cluster phosphorylation of DNA-PKcs promotes Alt-EJ-mediated CSR.36 37 58 recombination. Correspondingly, DNA-PKcs -/-(null) or Artemis -/mice are born of normal size at 59 the expected ratio but develop severe combined immunodeficiency (SCID) (4-6). Patients with 60 4hypomorphic mutations in DNA-PKcs or Artemis also develop SCID (12, 13). Mature B cells 61 undergo CSR, which replace the initially expressed IgM constant region with another 62 downstream constant region encoding a different isotype, to generate antibodies with different 63 effector functions. The cNHEJ pathway plays an important role in CSR. But in cells lacking a 64 core cNHEJ factor (e.g., Lig4 or Xrcc4), up to 25-50% of CSR can be achieved by the alternative 65 end-joining (Alt-EJ) pathway that preferentially uses microhomology (MH) at the junctions. 66 Consistent with DNA-PKcs and Artemis being dispensable for direct end-ligation, DNA-PKcs -/-67 B cells only have moderate defects in CSR (14, 15). Nevertheless, in recent high-throughput 68 sequence analyses, we found that CSR junctions recovered from DNA-PKcs -/-B cells contained 69 increased chromosomal translocations and extensive end-resection, and preferentially used MHs 70 (16), suggesting that the seemingly robust CSR achieved in DNA-PKcs -/cells is primarily 71 mediated by the Alt-EJ pathway like those in Lig4 -/or Xrcc4 -/-B cells (17, 18). Accordingly, 72 human patients with spontaneous mutations in DNA-PKcs show severe defects in both V(D)J 73 recombination and CSR and increased MH in the residual CSR junctions (12, 19).
74Active DNA-PK phosphorylates many substrates, among which, DNA-PKcs is the best-75 characterized...